Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile

NMD Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
June 2016
Website
http://www.nmdpharma.com/

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.

Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile

NMD Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
June 2016
Website
http://www.nmdpharma.com/

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.

NMD Pharma

Investment area
Seed Investments
Region
Europe
Date of investment
June 2016
Website
Visit their website

NMD Pharma is developing novel treatments for Neuromuscular diseases such as Myasthenia gravis and ALS. The company is in preclinical development.

Contact person
Morten Graugaard Døssing, Partner
Go to profile
Contact person
João Ribas, Principal
Go to profile